Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care stories included a huge ruling against one opioid maker and a settlement offer from another; an expert panel calling for broader screening for hepatitis C; a review showing there are more fatal events linked to a multiple sclerosis drug than previously known.
Listen above or through one of these podcast services:
What We're Reading: Purdue Pharma Settlement; HCV Screening; Medicare for All Support
Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought
FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure
5 Things to Look for at the European Society of Cardiology 2019 Congress
Keeping Glucose in Range, With the Right Tools and Treatment for Management
IVBM: Advancing Oncology Quality Through Value-Based Care
Read more about the stories in this podcast:
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen